ICON draws bullish view at Leerink on business model Sep. 18, 2024 3:28 PM ET By: Dulan Lokuwithana , SA News Editor [Seeking Alpha]
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Seeking Alpha
Analyst Michael Cherny argued that ICLR, a leading pure play contract research organization, has generated sustainable sales and adjusted EBITDA growth over the past few years thanks to its large pharma-led customer base. That business setup, comprising 50% large biopharma and only 15% smaller biotechs, has helped the company withstand the impact from inconsistent or slower biotech funding, an issue its smaller customers have faced. “ICLR's current book of business, weighted at roughly 50% large biopharma and only 15% capital-market-dependent biotech, has helped insulate results from the pullback in biotech funding that has impacted clinical trial starts,” Cherny wrote. The analyst issued a $379 per share target on the stock, assuming a multiple in line with its peer IQVIA ( IQV ), and implying a slight discount to the stock's pandemic-driven five-year average multiple. Recommended For You More Trending News Recommended For You More Trending News About ICLR Stock
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- IQVIA Holdings Inc. (NYSE: IQV) had its price target raised by analysts at Robert W. Baird from $251.00 to $256.00. They now have a "neutral" rating on the stock.MarketBeat
- India Clinical Trials Market By Region, Competition, Forecast & Opportunities, 2020-2024 & 2024-2030 [Yahoo! Finance]Yahoo! Finance
- IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership AwardBusiness Wire
- IQV Gains From Clinical Development Capabilities Amid Low Liquidity [Yahoo! Finance]Yahoo! Finance
- IQVIA Holdings' (NYSE:IQV) investors will be pleased with their decent 52% return over the last five years [Yahoo! Finance]Yahoo! Finance
IQV
Earnings
- 7/22/24 - Beat
IQV
Sec Filings
- 8/29/24 - Form 4
- 8/27/24 - Form 144
- 8/15/24 - Form SC
- IQV's page on the SEC website